EC Number   |
Natural Substrates |
|---|
   2.8.2.15 | 3'-phosphoadenylyl sulfate + 1-naphthol |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + 3,4-dihydroxyphenylacetic acid |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + 3alpha-hydroxytibolone |
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + 3beta-hydroxytibolone |
sulfation inactivates the hydroxylated metabolite of tibolone, a synthetic steroid used for the treatment for climacteric symptoms and postmenopausal osteoporosis |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + 4-androstene-3,17-dione |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + 4-nitrophenol |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + beta-estradiol |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + cholesterol |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + dehydroepiandrosterone |
- |
| 2.8.2.15 | 3'-phosphoadenylyl sulfate + dehydroepiandrosterone |
variant haplotypes in tissues possessing alterations in activity or stability may alter the plasma levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate thereby altering the conversion of dehydroepiandrosterone in tissues, overview |
